For a long time, doctors have sought viable treatments for debilitating depression . Now indicates copyright therapy, provided typically intravenously , appears to offer real breakthrough for patients who haven't benefited from standard antidepressants . Though largely considered a developing treatment , preliminary findings are showing remarkable